METLIFE INC

NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$15.9M2026 Q3
Positions7
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

METLIFE INC reported 7 positions worth $15.9M as of September 30, 2026 (13F filed November 16, 2026). Largest holding: SPY (31.6%).

7 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 SPYSPDR S&P 500$5.0M31.61%6,602——-3.0%
▸ 2 GLINInvinsaicinas A CF$3.4M21.50%85,085———
▸ 3 ECHIshares Msci Chile$3.1M19.58%82,499———
▸ 4 ILFIshares Latin America$2.3M14.68%67,764———
▸ 5 EWJIshares Msci Japan$953.0K5.99%9,782———
▸ 6 IEVIshares Europe ETF$624.1K3.92%8,777———
▸ 7 EPPIshares Msci Pacific$433.3K2.72%7,877———

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does METLIFE INC hold as of Q3 2026?

METLIFE INC reported 7 positions worth $15.9M in its Q3 2026 13F filing. Largest positions: SPY (31.6%), GLIN (21.5%), ECH (19.6%), ILF (14.7%) and EWJ (6.0%).

What did METLIFE INC buy in Q3 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did METLIFE INC sell in Q3 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.